Search research articles
Contact Us
Filters
Showing results (611-620 of 623) with videos related to
Page
of 63
Sort By:
Neurologia
|
January 29, 2020
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
J E Meca-Lallana, M Fernández-Prada, E García Vázquez, et al.
Brain : a Journal of Neurology
|
February 18, 2015
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
Ester Cantó, Mar Tintoré, Luisa M Villar, et al.
Journal of Immunological Methods
|
June 28, 2011
Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice
V Abraira, J C Alvarez-Cermeño, R Arroyo, et al.
Revista Espanola De Anestesiologia Y Reanimacion
|
March 10, 2001
[Survey of the deficit of anesthesiologists in Catalonia and analysis of the situation made by 47 department heads]
J J Arén, F Aroles, J M Bausili, et al.
Brain : a Journal of Neurology
|
August 5, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis
Enric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente, et al.
Annals of Neurology
|
January 13, 2015
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
Luisa M Villar, Lucienne Costa-Frossard, Thomas Masterman, et al.
The New England Journal of Medicine
|
May 27, 2021
A Novel Circulating MicroRNA for the Detection of Acute Myocarditis
Rafael Blanco-Domínguez, Raquel Sánchez-Díaz, Hortensia de la Fuente, et al.
JAMA Neurology
|
June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
Nicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.
G3 (Bethesda, Md.)
|
May 20, 2016
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients
A Dessa Sadovnick, Anthony L Traboulsee, Cecily Q Bernales, et al.
Frontiers in Neurology
|
January 7, 2021
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Inmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.
Page
of 63
Search research articles
Search
Showing results (611-620 of 623) with videos related to
Sort By:
Page
of 63
Neurologia
|
January 29, 2020
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
J E Meca-Lallana, M Fernández-Prada, E García Vázquez, et al.
Brain : a Journal of Neurology
|
February 18, 2015
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
Ester Cantó, Mar Tintoré, Luisa M Villar, et al.
Journal of Immunological Methods
|
June 28, 2011
Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice
V Abraira, J C Alvarez-Cermeño, R Arroyo, et al.
Revista Espanola De Anestesiologia Y Reanimacion
|
March 10, 2001
[Survey of the deficit of anesthesiologists in Catalonia and analysis of the situation made by 47 department heads]
J J Arén, F Aroles, J M Bausili, et al.
Brain : a Journal of Neurology
|
August 5, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis
Enric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente, et al.
Annals of Neurology
|
January 13, 2015
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
Luisa M Villar, Lucienne Costa-Frossard, Thomas Masterman, et al.
The New England Journal of Medicine
|
May 27, 2021
A Novel Circulating MicroRNA for the Detection of Acute Myocarditis
Rafael Blanco-Domínguez, Raquel Sánchez-Díaz, Hortensia de la Fuente, et al.
JAMA Neurology
|
June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
Nicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.
G3 (Bethesda, Md.)
|
May 20, 2016
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients
A Dessa Sadovnick, Anthony L Traboulsee, Cecily Q Bernales, et al.
Frontiers in Neurology
|
January 7, 2021
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Inmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.
Page
of 63